Diphtheria Market Size Projected To Reach $12.35 Billion By 2034 With A Cagr Of 6.8%

The Diphtheria Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Diphtheria Market?
In recent times, there has been a significant expansion in the diphtheria market size. A surge from $8.91 billion in 2024 to $9.51 billion in 2025 has been projected with a compound annual growth rate (CAGR) of 6.7%. Factors contributing to the growth during the historical period include the development of vaccines, implementation of immunization campaigns, heightened awareness, and improvements in healthcare infrastructure.

In the coming years, the diphtheria market is anticipated to experience substantial growth, with projections showing it reaching $12.35 billion in 2029, courtesy of a compound annual growth rate (CAGR) of 6.8%. The growth anticipated in the forecast duration can be credited to factors such as the emergence of outbreaks, programs aimed at booster vaccination, global travel and migration, and readiness in public health. Major trends to look out for during the forecast period comprise combination vaccines, the use of telemedicine for vaccination purposes, initiatives toward vaccine equity and public-private collaboration.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13016

What Are the Different Diphtheria Market Segments?
The diphtheria market covered in this report is segmented -

1) By Type: Diphtheria, Skin Diphtheria, Other Types
2) By Diagnosis: Physical Examination, Throat Culture, Other Diagnosis
3) By Treatment: Antibiotics, Antitoxin, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Diphtheria: Respiratory Diphtheria, Non-respiratory Diphtheria
2) By Skin Diphtheria: Cutaneous Diphtheria
3) By Other Types: Diphtheritic Myocarditis, Diphtheritic Neuritis

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp

What Are the Primary Drivers Shaping the Diphtheria Market?
The increase in bacterial infections is predicted to accelerate the development of the diphtheria market. Bacterial infections refer to illnesses or conditions caused by bacterial growth or the toxins they produce when they infect the body. Diphtheria is a grave infection instigated by bacterial strains that weaken the immune system and favour the proliferation of Corynebacterium diphtheria. In September 2024, as per GOV.UK, a UK government website, during the financial year 2022 to 2023, NHS acute trusts in England reported a total of 38,757 instances of E. coli bacteremia, out of which 7,881 cases (20.3%) were determined to be hospital-onset infections. Thus, the escalating prevalence of bacterial infections is contributing to the diphtheria market's expansion. The advancement of the diphtheria market will be fuelled by the growth of immunization programs. Immunization programs consist of an assemblage of services that protect people from vaccine-preventable illnesses by offering vaccinations. These provisions aim to decrease illness, disability, and death resulting from diseases that are preventable through vaccination. People are given diphtheria and a variety of other vaccines through immunization programs in distinct countries and regions. According to the United Nations International Children's Emergency Fund, a UN organization responsible for providing support for children's developmental and humanitarian needs worldwide, in July 2023, the global coverage for the 3rd dose of DTP (Diphtheria, Tetanus, Pertussis) vaccination (DTP3) rose from 81% in 2021 to 84% in 2022 via immunization. Hence, the expansion of immunization programs is contributing to the diphtheria market's growth.

Which Companies Are Leading in the Diphtheria Market?
Major companies operating in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

What Are the Major Trends Shaping the Diphtheria Market?
Leading entities in the diphtheria market are focusing on crafting innovative medications and securing approvals in order to maintain their market dominance. To illustrate, GlaxoSmithKline PLC, a pharmaceutical and biotechnology firm headquartered in the UK, revealed in October 2022 that the US Food and Drug Administration (FDA) had approved its BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap) for vaccination during the third month of gestation, in order to ward off pertussis (whooping cough) in infants below two months old. The Tdap vaccine, when administered during pregnancy, offers optimal protection against whooping cough to neonates in their early life months. The immunization allows protective antibodies to be passed from the mother to the child during gestation.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

What Are the Top Revenue-Generating Geographies in the Diphtheria Market?
Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Diphtheria Market?
2. What is the CAGR expected in the Diphtheria Market?
3. What Are the Key Innovations Transforming the Diphtheria Industry?
4. Which Region Is Leading the Diphtheria Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.